Biotech
Celgene
Celgene raises $90B Public at $95B valuation
$90B
Total Raised
Public
Latest Round
1986
Founded
7000+
Employees
86 Morris Avenue, Summit, NJ 07901
1 min read
Quick Facts
Valuation
$95B
Latest Round Size
$90B
Latest Round Date
January 2024
Celgene: Public Funding Round
Celgene has successfully raised $90B in Public funding, reaching a valuation of $95B.
Company Overview
Biotechnology company
Funding Details
The Public round was led by Bristol Myers Squibb.
Company Information
- Headquarters: 86 Morris Avenue, Summit, NJ 07901
- Founded: 1986
- Employees: 7000+
- Category: Biotech
Investment
Celgene plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Bristol Myers Squibb: Verified investor in Public
Key Investors
Bristol Myers Squibb
Lead Investor
Verified investor in Public
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Torl Biotherapeutics
Torl Biotherapeutics raises $96M Series C at $500M valuation
Torl Biotherapeutics raises $96M in Series C at $500M valuation. Antibody-based immunotherapies for cancer patients...
Editorial Team
Oct 10, 2025
1 min read•$96M
Biotech
Nilo Therapeutics
Nilo Therapeutics raises $101M Series A at $450M valuation
Nilo Therapeutics raises $101M in Series A at $450M valuation. Developing therapies based on neuro-immunology research...
Editorial Team
Oct 9, 2025
1 min read•$101M
Biotech
Arthrosi Therapeutics
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
Editorial Team
Oct 8, 2025
1 min read•$153M